Delayed Primary Closure of Skin in Emergency Caesarean Section

Comparative Study of Outcome Between Primary Closure and Delayed Primary Closure of Skin Incision in Emergency Caesarean Section

Pregnant mothers requiring emergency cs with history of ruptured membranes would be allocated randomly into two groups in an aim to study the comparative outcome of different methods of skin closure namely primary and delayed primary closure on the incidence of wound infections requiring secondary closures and to detect the associated risk factors increasing chance of surgical site infections.

Study Overview

• Status: Completed
• Conditions: Cesarean Wound Disruption; Cesarean Section; Infection
• Intervention / Treatment: Procedure: Primary closure of skin incision in Caesarean section in active comparator group; Procedure: Delayed primary closure of skin incision in Caesarean section in experimental group

Detailed Description

OBJECTIVE

• To compare the effect of two different methods of skin wound closure namely Primary Closure and Delayed Primary Closure on the incidence of wound infection and requirement for secondary skin wound repair after emergency caesarean section in patients with ruptured membranes.

RESEARCH HYPOTHESIS Caesarean Sections (CS) in emergency situation where amniotic membrane is ruptured are clean contaminated procedures which are associated with 10-20% wound disruptions. Delayed Primary Closure for managing contaminated wounds is a concept well recognized by military surgeons, which reduces wound infections. Investigators wish to conduct this prospective study to determine the efficacy of using this technique of wound closure in Caesarean Sections in patients with history of ruptured amniotic membranes. Investigators wish to study and compare the effect of this technique versus conventional primary skin closure on wound infection and incidence of secondary wound suturing in CS with ruptured membranes.

MATERIALS AND METHODS:

1. STUDY DESIGN: Randomized controlled Trial
2. STUDY SETTING: Tertiary teaching hospital-based trial involving obstetric patients undergoing Caesarean delivery.
3. PLACE OF STUDY: Department of Obstetrics and Gynecology, Calcutta National Medical College and Hospital, Kolkata.
4. PERIOD OF STUDY: From 1st March 2020 to 15th June 2021.
5. SAMPLE SIZE: As no similar study was found in literature related to obstetric population, we have chosen an arbitrary sample size of 30 in case group and 30 in control group in this Pilot study.
6. STUDY POPULATION:

INCLUSION CRITERIA :

• Parturients admitted with rupture of membranes undergoing emergency CS

EXCLUSION CRITERIA :

• Presence of intact membranes
• Incision other than Pfannenstiel
• Presence of pre-existing infection at the site of skin incision
• Presence of obvious chorioamnionitis
• Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.

• Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.

  i) PROCEDURE:

Mothers undergoing emergency CS for various indications after rupture of membranes will be randomly allocated to two groups Study group to undergo Delayed Primary Closure of skin incision and Control group to undergo Primary closure of skin incision, after appropriate consenting.

During CS Pfannenstiel incision will be made in the skin. All patients will receive prophylactic antibiotic within thirty minutes of making abdominal incision. Depending upon the duration of membrane rupture wound will be defined either contaminated (duration of membrane rupture ≥ 12 hours) or clean contaminated (duration of membrane rupture ≤12 hours).

At the end of the procedure after closure of rectus sheath in the Study group, interrupted stitches will be taken through skin and subcutaneous tissue with 1-0 monofilament suture but knots will not be tightened and skin will be left open. Following operation, from next day onwards dressing of the wound will be done for 3 days. On 4th day, the monofilament stitches will be tightened under local anaesthesia to appose the skin. Thereafter, sutures will be removed on 7th day after operation.

In the Control group wound margins will be apposed by primary closure by interrupted stitches using 1-0 monofilament and stitches will be removed on 6th day after operation.

If there is abnormal discharge from wound, wound swabs will be taken for bacterial culture sensitivity test.

If there is wound dehiscence, timing of secondary closure will be decided based on wound health and presence of adequate granulation tissue after a period of regular wound dressing.

STASTICAL ANALYSIS PLAN Statistical methods- Linear data will be represented a mean ± standard deviation for normally distributed data and as mean (interquartile range (IQR)) for not-normally distributed data. Categorical data will represented as percentage (frequency). Comparison of means will be done with Mann Whitney U test and comparison of proportions with Chi - squared test or Fisher's exact test as appropriate. Multivariate modeling with logistic regression will be used to compare different variables between the primary closure and delayed primary closure groups.

• Study Type: Interventional
• Enrollment (Actual): 70
• Phase: Not Applicable

Contacts and Locations

Study Locations

• India
  • West Bengal
    • Kolkata, West Bengal, India, 700047
      • Calcutta National Medical College and Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 40 years (ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

INCLUSION CRITERIA :

• Parturients admitted with rupture of membranes undergoing emergency CS

EXCLUSION CRITERIA :

• Presence of intact membranes
• Incision other than Pfannenstiel
• Presence of pre-existing infection at the site of skin incision
• Presence of obvious chorioamnionitis
• Presence of any immunosuppressive condition including HIV, intake of immunosuppressive medication, h/o chemotherapy, haematological malignancies, etc.
• Presence of other conditions interfering with wound healing like Tuberculosis, Diabetes, collagen disorders, etc.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
ACTIVE_COMPARATOR: Primary closure of Cesarean wound; Immediate closure of skin incision where healing occurs by primary intention	Procedure: Primary closure of skin incision in Caesarean section in active comparator group; Primary closure of skin wound (incisional) at the time of emergency Caesarean section in active comparator group
EXPERIMENTAL: Delayed primary closure of Cesarean wound; Delayed closure of skin incision following regular wound dressing for 2 to 3 days.	Procedure: Delayed primary closure of skin incision in Caesarean section in experimental group; Delayed closure of skin wound of emergency Caesarean section following wound dressing for 2-3 days in experimental group

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Surgical site infections requiring secondary closure	Incidence of surgical site infections requiring secondary closure	6 days from the day of surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prolonged hospital stay	Requiring prolonged hospital stay due to wound infection	more than 7 days after surgery

Collaborators and Investigators

• Sponsor: Dr.Jhuma Biswas
• Investigators: Principal Investigator: Jhuma Biswas, MBBS, MS, Dept. of Obstetrics and Gynecology, Calcutta National Medical College and Hospital

Study record dates

Study Major Dates

• Study Start (ACTUAL): March 1, 2021
• Primary Completion (ACTUAL): June 15, 2021
• Study Completion (ACTUAL): June 15, 2021

Study Registration Dates

• First Submitted: October 8, 2020
• First Submitted That Met QC Criteria: October 8, 2020
• First Posted (ACTUAL): October 14, 2020

Study Record Updates

• Last Update Posted (ACTUAL): October 1, 2021
• Last Update Submitted That Met QC Criteria: September 27, 2021
• Last Verified: September 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Emergencies
• Other Study ID Numbers: ECR/771/Inst/WB/2015/RR-18

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: IPD would be used for this study only

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No